Stock HTGMQ HTG MOLECULAR DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News HTG Molecular Diagnostics, Inc.

Equities

HTGMQ

US40434H3021

Delayed OTC Markets
Other stock markets
 12:38:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0015 USD 0.00% Intraday chart for HTG Molecular Diagnostics, Inc. -40.00% +15.38%
2023 Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. CI
2023 Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.
CI
Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.
CI
Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.
CI
HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index
CI
HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index
CI
Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer
CI
HTG Molecular Diagnostics, Inc. Filed for Bankruptcy
CI
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention
AQ
HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization
CI
Top Premarket Gainers
MT
HTG Highlights the Advantages of Its Drug Discovery Engine
AQ
HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K
PU
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
AQ
HTG MOLECULAR DIAGNOSTICS, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)
AQ
HTG Provides Update on Drug Discovery Partnering Initiative
AQ
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
AQ
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HTGMQ Stock
  4. News HTG Molecular Diagnostics, Inc.